Compare KZIA & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZIA | BNZI |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.5M | 9.6M |
| IPO Year | 1999 | N/A |
| Metric | KZIA | BNZI |
|---|---|---|
| Price | $10.14 | $1.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $17.67 | ★ $23.00 |
| AVG Volume (30 Days) | 292.8K | ★ 434.7K |
| Earning Date | 12-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,199,108.00 | ★ $10,650,176.00 |
| Revenue This Year | N/A | $223.24 |
| Revenue Next Year | N/A | $31.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.06 |
| 52 Week Low | $2.86 | $1.02 |
| 52 Week High | $17.40 | $27.00 |
| Indicator | KZIA | BNZI |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 33.66 |
| Support Level | $8.91 | $1.02 |
| Resistance Level | $12.20 | $1.26 |
| Average True Range (ATR) | 2.21 | 0.11 |
| MACD | -0.44 | 0.02 |
| Stochastic Oscillator | 14.72 | 3.04 |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.